Updated on 29 May 2012
The appointment reflects AusBiotech's focus on attracting capital to the industry
Singapore: AusBiotech has appointed Dr Mark Harvey to its board, to join the leadership team of AusBiotech in its efforts to grow and attract capital to the biotechnology industry.
"I'm pleased to announce the invited appointment to the AusBiotech Board of well-respected investment manager and venture capitalist, Dr Mark Harvey," said Dr Deborah Rathjen, Chair of the AusBiotech Board.
"With capital widely-acknowledged as the ‘life-blood' of Australia's promising biotechnology sector, Mark's expertise in the investment community and specific experience in the life sciences sector will make him a valuable addition to the Board."
The AusBiotech constitution allows for both elected and appointed board members, to ensure balanced representation, skills and experience, to enable effective leadership of the industry organisation.
"The appointment reflects AusBiotech's focus on the attraction of capital to the sector and supports the work being undertaken at a policy level and in the AusBiotech global investment series, which provides a platform for Australian companies seeking partnering and investment," said Dr Rathjen.